Trial Profile
An Open-Label Study to Explore the Clinical Efficacy of GS 7977 (Sofosbuvir -Sovaldi) with Ribavirin as Pre-Emptive Administration in Transplant-Recipients with Hepatitis C Virus (HCV) active infection
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 May 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 May 2015 New trial record